XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Supplemental Information (Notes)
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Information Supplemental Information
Equity Method Investments
LACC, LLC Joint Venture
On March 15, 2022, the Company completed the acquisition of an additional 3.2% of the membership interests in LACC, LLC ("LACC"), from Lotte Chemical Corporation for $89. The Company accounts for its investment in LACC under the equity method of accounting and changes for the nine months ended September 30, 2022 were as follows:
Investment in LACC
Balance at December 31, 2021$943 
Cash contributions87 
Additional interest purchased89 
Depreciation and amortization(32)
Balance at September 30, 2022$1,087 
Other Assets, Net
Other assets, net were $575 and $417 at September 30, 2022 and December 31, 2021, respectively. Deferred turnaround costs, net of accumulated amortization, included in other assets, net were $343 and $261 at September 30, 2022 and December 31, 2021, respectively.
Accrued and Other Liabilities
Accrued and other liabilities were $1,461 and $1,196 at September 30, 2022 and December 31, 2021, respectively. Accrued rebates and accrued income taxes, which are components of accrued and other liabilities, were $234 and $141, respectively, at September 30, 2022 and $213 and $88, respectively, at December 31, 2021. No other component of accrued and other liabilities was more than five percent of total current liabilities. Accrued liabilities with related parties were $39 and $49 at September 30, 2022 and December 31, 2021, respectively.
Restructuring, Transaction and Integration-Related Costs
The restructuring, transaction and integration-related costs of $6 for the three months ended September 30, 2022 and $24 for the nine months ended September 30, 2022, and of $6 for the three and nine months ended September 30, 2021, primarily consisted of costs associated with the Company's recent acquisitions.
Non-cash Investing Activity
Capital expenditure related liabilities, included in accounts payable and accrued and other liabilities, were $149 and $74 at September 30, 2022 and September 30, 2021, respectively.
Operating Lease Supplemental Cash Flow
Right-of-use assets obtained in exchange for operating lease obligations were $138 and $63 for the nine months ended September 30, 2022 and 2021, respectively.